Association between glucocorticoids treatment and viral clearance delay in patients with COVID-19: a systematic review and meta-analysis
Abstract Background Evidence of glucocorticoids on viral clearance delay of COVID-19 patients is not clear. Methods In this systematic review and meta-analysis, we searched for studies on Medline, Embase, EBSCO, ScienceDirect, Web of Science, Cochrane Library, and ClinicalTrials.gov from 2019 to Apr...
Main Authors: | Jianbo Li, Xuelian Liao, Yue Zhou, Luping Wang, Hang Yang, Wei Zhang, Zhongwei Zhang, Yan Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-06548-z |
Similar Items
-
Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
by: Jingjing Ji, et al.
Published: (2020-09-01) -
Relationship between glucocorticoids and viral load during the Omicron wave in mainland China
by: Guangxu Bai, et al.
Published: (2023-11-01) -
An updated analysis of viral clearance unit operations for biotechnology manufacturing
by: Opeyemi O. Ajayi, et al.
Published: (2022-01-01) -
Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatment
by: Victor Ho-Fun Lee, et al.
Published: (2023-07-01) -
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance
by: Mihaela Zlei, et al.
Published: (2022-09-01)